来自B细胞的IL-10促进了由Bcl-3调节的喘中的过敏敏感化
Guojun Qian1,2, Wenxia Jiang3, Donglin Sun4
1Affiliated Cancer Hospital/Institute and GMU-GIBH Joint School of Life Sciences of Guangzhou Medical University, The Guangdong-Hong Kong-Macau Joint Laboratory for Cell Fate Regulation and Diseases, State Key Laboratory of Respiratory Disease, 511436, Guangzhou, China. qianguojun@gzhmu.edu.cn.
Cellular & molecular immunology
|August 31, 2023
概括
B细胞衍生IL-10通过增加CCL-20和树突细胞招募来促进过敏喘. Bcl-3蛋白抑制了这一过程,为过敏性喘提供了潜在的治疗点.
科学领域:
- 免疫学 免疫学 免疫学
- 过敏研究 研究过敏
- 呼吸系统医学 呼吸系统医学
背景情况:
- 过敏性喘的发病包括肺上皮和树突细胞 (DCs).
- 介质素-10 (IL-10) 在免疫反应中具有复杂的作用.
- B细胞衍生的IL-10在过敏性喘中的作用尚未完全理解.
研究的目的:
- 研究B细胞衍生IL-10在家尘 (HDM) 引起的过敏喘中的作用.
- 通过Bcl-3阐明B细胞衍生IL-10的调节机制.
- 探索喘治疗中准BCL-3/IL-10轴的潜力.
主要方法:
- 使用了Bcl-3淘汰 (Bcl-3-/-) 的小鼠模型.
- 使用家用灰尘 (HDM) 诱导过敏性喘.
- 测量IL-10水平,CCL-20的产生和树突细胞的招募.
- 在敏感化过程中使用IL-10或IL-10受体阻塞.
主要成果:
- Bcl-3-/-小鼠表现出增加的IL-10和对HDM诱导喘的敏感性.
- IL-10与CCL-20水平呈正相关性,并促进其由肺上皮细胞产生.
- 阻断IL-10或IL-10受体可以降低HDM敏感性和喘发育.
- 缺乏B细胞衍生IL-10的小鼠对HDM诱导的喘有抗性.
- Bcl-3 抑制B细胞衍生IL-10的产生,防止喘.
结论:
- B细胞衍生的IL-10在过敏性喘中起着促炎作用.
- Bcl-3 作为 B 细胞衍生的 IL-10 的抑制剂,防止 HDM 诱导的喘.
- 准Bcl-3/IL-10通路是治疗过敏性喘的一个有希望的策略.
相关概念视频
01:24T Cell Types and Functions
1.1K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.1K
01:26Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
01:24B Cell Activation and Differentiation
1.8K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
1.8K
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
342
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
342
01:20Asthma: Pathogenesis and Management
442
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
442
01:19Antiasthma Drugs: Leukotriene Modifiers
353
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
353